Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2009
03/03/2009US7498493 Inbred corn line GH05-60231
03/03/2009US7498492 Adjusting fiber development in plants; obtain cells, transform with expression vector coding enzymatic protein, propagate plant and monitor fiber content in cells
03/03/2009US7498491 Soybean variety 4785923
03/03/2009US7498490 Soybean variety 4010165
03/03/2009US7498487 Soybean variety XB54X07
03/03/2009US7498485 Soybean variety 4676311
03/03/2009US7498483 Expression vector comprising nucleotide sequences coding transferase for use in enhancing triacylglycerols concentration in seeds
03/03/2009US7498482 Polynucleotide encoding polypeptide of given sequence; transformation to drought-resistant crops
03/03/2009US7498481 Using transponson activation to generate preferential phenotypes in corn; tissue engineering; plant transgenesis and improving agronomic or dietary qualities maize
03/03/2009US7498480 Comprises monopartite RNA viral vector for transformation and expression of heterologous genes in plants
03/03/2009US7498479 Animal model having a chimeric human liver
03/03/2009US7498455 Plant oils with altered oleic acid content
03/03/2009US7498448 Reacting thiophene with 3-halopropionyl halide or acryloyl halide in the presence of a Lewis acid to give 3-halo-1-(2-thienyl)-1-propanone; passing in hydrogen halide simultaneously or after the reaction; reducing the propanone with an enantioselective dehydrogenase; and aminating with methylamine
03/03/2009US7498429 AHAS small subunit promoter
03/03/2009US7498428 Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
03/03/2009US7498427 Expression vector comprising nucleotide sequences coding delta-9 fatty acid desaturase for use in transformation and propagation of plants with enhanced production of edible oils
03/03/2009US7498424 Bioassy for identifying compounds which prevent host proteins interation with viral protein associated with infection, replication, assembly or release; viricides
03/03/2009US7498420 Human monoclonal antibody for use in the diagnosis prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics
03/03/2009US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy
03/03/2009US7498416 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
03/03/2009US7498415 Culturing, gene expression, transformation; fab and fv fragments; biodrugs; anticarcinogenic agents, diabetes, acromegaly
03/03/2009US7498414 Comprising complementarity determining regions; recombinant host cells; fab fragments, fv fragments, diabodies, triabodies, and single domain antibodies; angiogenesis inhibitors; antitumor, antiproliferative, and anticarcinogenic agents; gene expression
03/03/2009US7498407 Vascular endothelial cell growth inhibitor, VEGI-192a
03/03/2009US7498316 Nucleic acid with 1st sequence encoding antisense RNAi specific for targeting regions of copper zinc superoxide dismutase that cause inherited amyotrophic lateral sclerosis, and a 2nd sequence encoding a RNAi resistant replacement gene with silent mutations encoding messenger RNA resistant to cleavage
03/03/2009US7498315 Oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers; non-toxic and effective in low doses
03/03/2009US7498314 Expression vectors and uses thereof
03/03/2009US7498313 Large circular target-specific antisense nucleic acid compounds
03/03/2009US7498306 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents
03/03/2009US7498300 Corticotropin releasing factor peptide for use in the treatment of nervous system and hypertensive disorders
03/03/2009US7498166 Contains promoter effective for gene expression in both bacterial and insect cells; construction of only a single vector is needed to express a polynucleotide inserted at a downstream cloning site; from recombinant baculovirus; polh and T7lac promoters; high throughput assay
03/03/2009US7498165 Rapidly cleavable SUMO fusion protein expression system for difficult to express proteins
03/03/2009US7498162 A gene expressed polypeptide is used in food, for treating food allergy
03/03/2009US7498161 Anticarcinogenic agents; gene directed enzyme prodrug therapy
03/03/2009US7498158 Termamyl-like alpha-amylase for starch conversion, ethanol, laundry, dish, hard surface cleaning, textile desizing and/or sweetner production
03/03/2009US7498157 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators
03/03/2009US7498154 Nucleotide sequences coding cytokine receptor for identifying modulators for prevention and treatment of infection, cell proliferative and autoimmune disorders
03/03/2009US7498153 Chimeric immunogens
03/03/2009US7498152 Interferon-alpha polypeptides and conjugates
03/03/2009US7498151 Variant TLR4 nucleic acid and uses thereof
03/03/2009US7498149 Proteins having effects of controlling cell migration and cell death
03/03/2009US7498143 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
03/03/2009US7498139 Using presence of procalcitonin or procalcitonin partial peptides to detect septicemia; determining proprotein concentrations in sample
03/03/2009US7498133 Cellulosic filter substrate for lysing cells, purifying nucleic acids and labelling blood transfusion bags
03/03/2009US7498131 High throughput separation and detection of nucleotide sequences and single nucleotide polymorphisms; anealing, replication, hybridization; ligation-dependent amplification assay followed by multiple injection; sequence determination; multichannel electrophoresis; complementary target-specific sections
03/03/2009US7498129 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification
03/03/2009US7498127 Drug screening for cytostatic agent intracellular signaling inhibitor such as antitumor agents, antirheumatic agents; cardiovascular disorders; producing within a cell a fragment of heparin binding-epidermal growth factor (HB-EGF); determination of nuclear export of PLZF protein
03/03/2009US7498037 Expression vector comprising nucleotide sequences coding malarial proteins for use as tool in generating vaccines against plasmodial infection; immunotherapy; antimalarial agents
03/03/2009US7498036 Optimized expression of HPV 58 L1 in yeast
03/03/2009US7498034 Imaging, diagnosis and treatment of disease
03/03/2009US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies
03/03/2009US7498024 Expression vector comprising nucleotide sequences coding foot and mouth viral, as well as, immunoglobulin sequences for use in generation imunotherapeutics
03/03/2009US7498017 Compositions for delivering nucleic acids to cells
03/03/2009CA2276108C Novel peptide, novel dna, and novel antibody
03/03/2009CA2259126C Manipulation of cellulose and/or .beta.-1,4-glucan
03/03/2009CA2238278C Antigenic protein originating in malassezia
03/03/2009CA2211018C Seed coat specific dna regulatory region and peroxidase
03/03/2009CA2200342C Overexpression of mammalian and viral proteins
03/03/2009CA2126806C Isolated nda sequence usable as a terminal zone in a chimeric gene for the modification of plants
02/2009
02/28/2009CA2597151A1 Hiv vaccine
02/26/2009WO2009026543A2 Cationic alpha-amino acid-containing biodegradable polymer gene transfer compositions
02/26/2009WO2009026456A2 Poxvirus methods and compositions
02/26/2009WO2009026448A1 Interaction screening methods, systems and devices
02/26/2009WO2009026445A2 Methods and compositions for post-transcriptional gene silencing
02/26/2009WO2009026317A2 Use of eif-5a1 sirna to protect islets cells from apoptosis and to preserve their functionality
02/26/2009WO2009026233A2 Self assembling peptide systems and methods
02/26/2009WO2009026152A1 Metabolomic profiling of prostate cancer
02/26/2009WO2009025819A1 Optical depolarization of cardiac tissue
02/26/2009WO2009025646A1 Alpha 1-3 n-galactosyltransferase with altered donor specificities
02/26/2009WO2009025622A1 Pancreatic stellate cell specific promoter and uses thereof
02/26/2009WO2009025527A2 Sirna of nf-kb p105 for inhibiting cell proliferation and migration and a composition comprising same
02/26/2009WO2009025470A2 Novel corynebacterium glutamicum promoter
02/26/2009WO2009025363A1 Method for production of succinic acid
02/26/2009WO2009025300A1 Peptide capable of binding to immunoglobulin
02/26/2009WO2009025296A1 Method of detecting methylated cytosine
02/26/2009WO2009025209A1 Method for preparation of recombinant dna
02/26/2009WO2009025159A1 Detection and treatment of schizophrenia
02/26/2009WO2009025149A1 Adnf receptor
02/26/2009WO2009025117A1 Cdca1 peptide and pharmaceutical agent comprising the same
02/26/2009WO2009025116A1 Cdh3 peptide and medicinal agent comprising the same
02/26/2009WO2009024986A2 Regulatory sequences derived from il-10 promoter and uses thereof in modulation of immune response
02/26/2009WO2009024789A1 Hiv-2 antigenic peptides
02/26/2009WO2009024773A1 Device, system and method for processing a sample
02/26/2009WO2009024726A2 Method for purifying or detecting a target protein
02/26/2009WO2009024653A1 Anti-idiotypic antibodies which neutralise the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii
02/26/2009WO2009024593A1 Improved methods for the formation of disulphide bonds
02/26/2009WO2009024591A1 Pvii phage display
02/26/2009WO2009024567A1 Production method
02/26/2009WO2009024327A2 New proteins for use in human and animal staphylococcus infections
02/26/2009WO2009024239A2 Permissive cells and uses thereof
02/26/2009WO2009024208A1 Hypoallergenic molecules
02/26/2009WO2009024142A2 Protease-stable, cell wall-lysing enzymes
02/26/2009WO2009023961A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease
02/26/2009WO2009023959A1 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases
02/26/2009WO2009008908A3 Structure-activity relationships
02/26/2009WO2009006638A3 Peptides facilitating retrograde transport and their uses
02/26/2009WO2009006438A3 Copy dna and sense rna
02/26/2009WO2009000891A3 Linear expression constructs for production of influenza virus particles
02/26/2009WO2008157459A3 Methods and systems for identifying molecular pathway elements
02/26/2009WO2008157157A3 Drought-resistant plants and method for producing the plants
02/26/2009WO2008154352A3 Genetic markers associated with endometriosis and use thereof